Aurora to Use Oracle's Informatics Muscle to Run More Efficient Clinical Trials; PGx in Long View
February 09, 2011
Aurora to Use Oracle's Informatics Muscle to Run More Efficient Clinical Trials; PGx in Long View
While Aurora's long-term plans include research using pharmacogenomic strategies, for the time being it will most likely use genomics for biomarker discovery work.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Payors Weigh in on Interface of Personalized Medicine and Comparative Effectiveness Research
December 8, 2010 / Pharmacogenomics Reporter - UnitedHealthcare Sees Need for National Registry to Track Use, Set Coverage of Molecular Tests
November 7, 2012 / Pharmacogenomics Reporter - AstraZeneca, HealthCore CER Collaboration Will Look at Genomically Defined Subpopulations
February 16, 2011 / Pharmacogenomics Reporter - KineMed, MedImmune Studying Role of Protein Dynamics in Neurodegenerative Diseases
May 21, 2013 / GenomeWeb Daily News - Oxford Cancer Biomarkers Developing CDx Biomarkers for AstraZeneca
April 16, 2013 / GenomeWeb Daily News